MSI2 and cancer: BCAT1 overexpression results in increased BCAA catabolism in cancer and is upregulated by several molecules (e.g., hypoxia-inducible factor 1, SMAD5, cMyc, Musashi2) although some cancers favor the reverse reaction [38,39].